Envoy Medical, Inc.
COCH
$0.68
$0.000.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.11% | -25.18% | -26.49% | -28.62% | -28.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.11% | -25.18% | -26.49% | -28.62% | -28.80% |
| Cost of Revenue | -7.82% | 0.12% | -2.07% | 10.43% | -2.37% |
| Gross Profit | 14.31% | -13.12% | -12.14% | -36.73% | -16.44% |
| SG&A Expenses | 6.89% | -7.00% | -8.60% | -13.55% | -4.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.57% | -4.92% | -1.12% | -0.39% | 4.32% |
| Operating Income | -14.66% | 4.65% | 0.74% | -0.04% | -4.89% |
| Income Before Tax | -14.24% | -3.40% | -56.96% | 14.55% | 30.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.24% | -3.40% | -56.96% | 14.55% | 30.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.24% | -3.40% | -56.96% | 14.55% | 30.29% |
| EBIT | -14.66% | 4.65% | 0.74% | -0.04% | -4.89% |
| EBITDA | -14.12% | 5.15% | 1.20% | 0.27% | -4.71% |
| EPS Basic | 16.43% | 3.87% | -57.12% | 28.65% | 47.21% |
| Normalized Basic EPS | 7.80% | 8.40% | 6.88% | 54.99% | 51.39% |
| EPS Diluted | 16.43% | 4.05% | -55.29% | 29.04% | 47.42% |
| Normalized Diluted EPS | 7.80% | 8.40% | 4.43% | 54.40% | 50.76% |
| Average Basic Shares Outstanding | 23.78% | 12.57% | 21.98% | 35.09% | 52.83% |
| Average Diluted Shares Outstanding | 23.78% | 12.57% | 20.16% | 32.78% | 49.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.35% | -0.28% | -- | -- | -- |